MedTrace Logo

Promoting Autonomy Through ExerCisE (PACE) in Outpatient Geriatric Clinics

NCT07787663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2026-08-26

No results posted yet for this study

Summary

Physical inactivity is highly prevalent among older adults and is associated with declines in physical function, independence, quality of life, and social participation.

The PACE tool provides 35 tailored physical activity programs for frail, community-dwelling older adults. Programs are prescribed by healthcare professionals using simple clinical criteria and can be delivered remotely. Previous research has demonstrated the feasibility, acceptability, safety, and effectiveness of adapted physical activity programs.

The main objective of the project is to implement PACE in the geriatric outpatient clinics (CEG) of the Institut Universitaire de Gériatrie de Montréal (IUGM) to prevent deconditioning, promote autonomy, and reduce the burden on caregivers and healthcare resources.

Conditions

Interventions

OTHER

PACE

The patient's mobility profile is determined using a decisional tree, which guides the prescription of an adapted physical activity (PA) program. The PACE tool includes 35 PA programs divided into 7 color-coded categories according to the physical components that should be prioritized (cardiorespiratory/muscular fitness, balance, and/or trunk mobility/stability). 5 difficulty levels provided. Each program includes 2 to 4 exercises (approx.15 min/day) and a walking goal ranging from 10 minutes (2 × 5 min) to 30 minutes (2 × 15 min). The program is prescribed daily for 12 weeks.

Sponsors & Collaborators

  • Université du Québec a Montréal

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-23
Primary Completion
2025-09-11
Completion
2025-09-11

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07787663 on ClinicalTrials.gov